Literature DB >> 16689213

Development of magnetic particle techniques for long-term culture of bone cells with intermittent mechanical activation.

Sarah H Cartmell1, Jon Dobson, Sarah B Verschueren, Alicia J El Haj.   

Abstract

Magnetic particles were coated with RGD and adhered to primary human osteoblasts. During a 21-day culture, the osteoblasts plus adhered magnetic particles underwent a daily exposure to a time-varying magnetic field via a permanent NdFeB magnet, thus applying a direct mechanical stress to the cells (Bmax approximately 60 mT). After 21 days, preliminary results show that the cells plus magnetic particles were viable and had proliferated. A von-kossa stain showed mineralized bone matrix produced at 21 days in the experimental group whereas the control groups showed no mineralized matrix production. Real-time reverse transcription-polymerase chain reaction at 21 days showed an upregulation of osteopontin from the experimental group in comparison to the control group of cells with adhered particles and no magnet applied. These preliminary results indicate that adherence of RGD-coated 4.5 microm ferromagnetic particles to primary human osteoblasts does not initiate cell necrosis up to 21 days in vitro. Also, mechanical stimulation of human osteoblasts by magnetic particle technology appears to have an influence on osteoblastic activity.

Entities:  

Mesh:

Year:  2002        PMID: 16689213     DOI: 10.1109/tnb.2002.806945

Source DB:  PubMed          Journal:  IEEE Trans Nanobioscience        ISSN: 1536-1241            Impact factor:   2.935


  17 in total

1.  Magnetic field application or mechanical stimulation via magnetic microparticles does not enhance chondrogenesis in mesenchymal stem cell sheets.

Authors:  A D Dikina; B P Lai; M Cao; M Zborowski; E Alsberg
Journal:  Biomater Sci       Date:  2017-06-27       Impact factor: 6.843

2.  The promotion of in vitro vessel-like organization of endothelial cells in magnetically responsive alginate scaffolds.

Authors:  Yulia Sapir; Smadar Cohen; Gary Friedman; Boris Polyak
Journal:  Biomaterials       Date:  2012-03-13       Impact factor: 12.479

Review 3.  Orthopaedic applications of nanoparticle-based stem cell therapies.

Authors:  Ian Wimpenny; Hareklea Markides; Alicia J El Haj
Journal:  Stem Cell Res Ther       Date:  2012-04-19       Impact factor: 6.832

4.  Iron oxide-based nanomagnets in nanomedicine: fabrication and applications.

Authors:  Meng Meng Lin; Hyung-Hwan Kim; Hyuck Kim; Mamoun Muhammed; Do Kyung Kim
Journal:  Nano Rev       Date:  2010-02-22

5.  Evaluation of the magnetic field requirements for nanomagnetic gene transfection.

Authors:  A Fouriki; N Farrow; M A Clements; J Dobson
Journal:  Nano Rev       Date:  2010-07-09

Review 6.  Recent advances in superparamagnetic iron oxide nanoparticles for cellular imaging and targeted therapy research.

Authors:  Yi-Xiang J Wang; Shouhu Xuan; Marc Port; Jean-Marc Idee
Journal:  Curr Pharm Des       Date:  2013       Impact factor: 3.116

Review 7.  Three-dimensional nanomagnetism.

Authors:  Amalio Fernández-Pacheco; Robert Streubel; Olivier Fruchart; Riccardo Hertel; Peter Fischer; Russell P Cowburn
Journal:  Nat Commun       Date:  2017-06-09       Impact factor: 14.919

8.  Safety implications of high-field MRI: actuation of endogenous magnetic iron oxides in the human body.

Authors:  Jon Dobson; Richard Bowtell; Ana Garcia-Prieto; Quentin Pankhurst
Journal:  PLoS One       Date:  2009-05-04       Impact factor: 3.240

9.  Receptor-targeted, magneto-mechanical stimulation of osteogenic differentiation of human bone marrow-derived mesenchymal stem cells.

Authors:  Bin Hu; Alicia J El Haj; Jon Dobson
Journal:  Int J Mol Sci       Date:  2013-09-23       Impact factor: 5.923

10.  Remotely Activated Mechanotransduction via Magnetic Nanoparticles Promotes Mineralization Synergistically With Bone Morphogenetic Protein 2: Applications for Injectable Cell Therapy.

Authors:  James R Henstock; Michael Rotherham; Hassan Rashidi; Kevin M Shakesheff; Alicia J El Haj
Journal:  Stem Cells Transl Med       Date:  2014-09-22       Impact factor: 6.940

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.